Customize Consent Preferences

We use cookies to help you navigate efficiently and perform certain functions. You will find detailed information about all cookies under each consent category below.

The cookies that are categorized as "Necessary" are stored on your browser as they are essential for enabling the basic functionalities of the site. ... 

Always Active

Necessary cookies are required to enable the basic features of this site, such as providing secure log-in or adjusting your consent preferences. These cookies do not store any personally identifiable data.

No cookies to display.

Functional cookies help perform certain functionalities like sharing the content of the website on social media platforms, collecting feedback, and other third-party features.

No cookies to display.

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics such as the number of visitors, bounce rate, traffic source, etc.

No cookies to display.

Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors.

No cookies to display.

Advertisement cookies are used to provide visitors with customized advertisements based on the pages you visited previously and to analyze the effectiveness of the ad campaigns.

No cookies to display.

Skip to content

Country

The Netherlands

Biography

Wim Jiskoot graduated as a pharmacist at Utrecht University (1987). In 1991 he obtained his PhD degree at Utrecht University with his thesis entitled 'Pharmaceutical Aspects of Monoclonal Antibodies'. As a postdoctoral fellow at the University of Utah, USA (1991–1993), he studied protein-ligand interactions using biophysical techniques. After his return to The Netherlands in 1994, he became head of the Department of Bacterial Vaccine Development at the Laboratory for Product and Process Development, National Institute of Public Health and the Environment (RIVM), Bilthoven, where he was in charge of the development of production processes for bacterial vaccines. In 1998 he became a staff member at the Department of Pharmaceutics.
In 2006, Wim became Full Professor at the Division of Drug Delivery Technology, Leiden/Amsterdam Center for Drug Research (LACDR), Leiden University. He heads the Biologics Group at the Center and is involved in research on vaccine delivery and unwanted immunogenicity of biopharmaceuticals. Professor Jiskoot has significant expertise in the field of formulation, delivery and biophysical characterization of therapeutic proteins and vaccines
 

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.